Windlas Biotech Limited (NSE:WINDLAS)
India flag India · Delayed Price · Currency is INR
1,002.95
+8.75 (0.88%)
Aug 29, 2025, 3:30 PM IST

Windlas Biotech Company Description

Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India.

The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services.

It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules.

In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies.

It also exports generic medicines, health supplements, and custom-branded formulations. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.

Windlas Biotech Limited
CountryIndia
Founded2001
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,154
CEOKomal Gupta

Contact Details

Address:
40/1, Mohabewala Industrial Area
Dehradun, Haryana 248 110
India
Phone91 135 660 8000
Websitewindlas.com

Stock Details

Ticker SymbolWINDLAS
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE0H5O01029
SIC Code2834

Key Executives

NamePosition
Komal GuptaChief Financial Officer and Chief Executive Officer
Ananta Narayan PandaCompany Secretary and Compliance Officer
Ashok Kumar WindlassWhole-Time Director
Hitesh WindlassMD and Executive Director
Manoj Kumar WindlassJoint MD and Executive Director
Pawan Kumar SharmaExecutive Director
Mohammed AslamPresident of Sales and Marketing
Om Prakash SuleSite Quality Head